This reagent is intended for in-vitro quantitative determination of Creatine Kinase in human serum and plasma.
Clinical Significance:
The determination of CK activity in plasma or serum provides a sensitive marker for the detection of skeletal muscle disease; and is also useful in diagnosis of myocardial infarction and cerebrovascular accidents.
| Method | Type | PackSize | Produt Type |
|---|---|---|---|
| DGKC | Liquixx | R1: 2 x 8 ml; R2: 2 x 2 ml | 120847 |
| DGKC | Powder | 5 x 2.2 ml | 120197 |